PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 207 filers reported holding PTC THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,076,580 | -17.9% | 174,000 | -2.2% | 0.88% | -49.6% |
| Q1 2023 | $8,622,320 | +125.9% | 178,000 | +78.0% | 1.74% | +116.9% |
| Q4 2022 | $3,817,000 | -53.4% | 100,000 | -38.7% | 0.80% | -49.6% |
| Q3 2022 | $8,183,000 | +95.2% | 163,000 | +55.7% | 1.59% | +84.5% |
| Q2 2022 | $4,193,000 | +167.6% | 104,656 | +149.2% | 0.86% | +111.3% |
| Q1 2022 | $1,567,000 | -12.6% | 42,000 | -6.7% | 0.41% | -17.7% |
| Q4 2021 | $1,792,000 | -50.4% | 45,000 | -53.7% | 0.50% | -52.3% |
| Q3 2021 | $3,613,000 | -22.4% | 97,100 | -11.8% | 1.04% | -18.9% |
| Q2 2021 | $4,654,000 | -1.8% | 110,100 | +10.0% | 1.28% | -5.4% |
| Q1 2021 | $4,740,000 | +158.0% | 100,100 | +232.6% | 1.35% | +148.0% |
| Q4 2020 | $1,837,000 | +30.6% | 30,100 | 0.0% | 0.55% | +27.0% |
| Q3 2020 | $1,407,000 | -7.6% | 30,100 | +0.3% | 0.43% | -5.7% |
| Q2 2020 | $1,522,000 | – | 30,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 160,372 | $7,594,000 | 6.15% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 408,000 | $19,319,000 | 5.11% |
| RTW INVESTMENTS, LP | 5,293,966 | $250,669,000 | 3.91% |
| GEORGE KAISER FAMILY FOUNDATION | 72,105 | $9,925,000 | 2.07% |
| SECTORAL ASSET MANAGEMENT INC | 504,928 | $23,908,000 | 1.81% |
| Redwood Investments, LLC | 385,014 | $18,230,000 | 1.60% |
| ARMISTICE CAPITAL, LLC | 1,396,000 | $66,101,000 | 1.52% |
| Integral Health Asset Management, LLC | 100,100 | $4,740,000 | 1.35% |
| Sofinnova Investments, Inc. | 466,840 | $22,105,000 | 1.33% |
| Chubb Ltd | 8,180 | $387,000 | 1.10% |